Skip to main content

Table 1 Dosimetric analysis for four different setup-field plans on the Halcyon

From: Treatment planning comparison of volumetric modulated arc therapy with the trilogy and the Halcyon for bilateral breast cancer

 

CBCT-H

CBCT-L

MV-H

MV-L

p

p < 0.05

PTV

      

 Dmean(Gy)

52.4 ± 0.3

52.0 ± 0.2

52.2 ± 0.2

52.1 ± 0.3

0.01

a

 D98(Gy)

48.5 ± 0.2

48.5 ± 0.3

48.5 ± 0.3

48.6 ± 0.4

0.95

 

 D2(Gy)

54.3 ± 0.60

53.6 ± 0.3

53.8 ± 0.4

53.7 ± 0.5

0.01

a,c,

 V107 (%)

16.1 ± 12.8

3.6 ± 2.8

7.9 ± 6.7

7.5 ± 10.8

0.03

a

 V110 (%)

0.8 ± 1.6

0.0 ± 0.0

0.1 ± 0.1

0.0 ± 0.1

0.09

 

 CI

0.86 ± 0.02

0.86 ± 0.02

0.86 ± 0.02

0.86 ± 0.02

0.96

 

 HI

11.6 ± 1.3

10.1 ± 1.1

10.6 ± 1.1

10.1 ± 1.4

0.06

 

Heart

      

 V5(%)

55.0 ± 9.3

30.5 ± 6.2

33.2 ± 8.4

29.4 ± 7.7

0.00

a,b,c

 V30(%)

1.1 ± 0.6

0.8 ± 0.5

1.0 ± 0.7

1.1 ± 0.7

0.62

 

 Dmean(Gy)

7.1 ± 0.7

5.6 ± 0.6

6.0 ± 0.9

5.7 ± 0.9

0.00

a,b,c

LV

      

 V5(%)

57.9 ± 11.2

35.7 ± 9.3

39.9 ± 11.6

36.0 ± 10.4

0.00

a,b,c

 V30(%)

2.6 ± 1.3

1.9 ± 1.0

2.5 ± 1.5

2.6 ± 1.5

0.56

 

 Dmean(Gy)

8.7 ± 1.3

6.8 ± 1.1

7.3 ± 1.5

6.9 ± 1.4

0.03

a,c

LAD

      

 V5(%)

97.5 ± 5.1

84.6 ± 13.4

85.1 ± 12.7

80.6 ± 14.5

0.02

c

 V30(%)

21.3 ± 13.8

14.3 ± 10.9

20.8 ± 15.0

21.6 ± 15.0

0.59

 

 Dmax(Gy)

39.5 ± 3.2

38.9 ± 3.1

39.7 ± 3.3

39.8 ± 3.5

0.92

 

 Dmean(Gy)

19.2 ± 4.7

17.2 ± 4.0

18.5 ± 4.6

18.2 ± 5.0

0.80

 

Lungs

      

 V5(%)

57.7 ± 8.9

43.7 ± 4.1

46.6 ± 7.4

43.7 ± 6.6

0.00

a,b,c

 V20(%)

14.9 ± 2.9

13.2 ± 2.5

14.7 ± 2.7

14.2 ± 2.4

0.47

 

 Dmean(Gy)

10.4 ± 1.1

9.1 ± 0.8

9.6 ± 1.0

9.3 ± 0.9

0.03

a

Liver

      

 Dmean(Gy)

6.9 ± 1.5

6.0 ± 1.1

6.5 ± 1.5

6.3 ± 1.4

0.54

 

Skin

      

 V40(%)

41.3 ± 9.2

40.4 ± 8.8

39.7 ± 9.2

39.2 ± 8.5

0.96

 

 V50(%)

0.3 ± 0.2

0.3 ± 0.2

0.1 ± 0.1

0.1 ± 0.1

0.12

 

B-P

      

 V5(%)

32.9 ± 4.5

27.6 ± 2.8

28.9 ± 3.5

28.0 ± 3.4

0.01

a,c

 V10(%)

19.9 ± 2.3

18.4 ± 1.9

19.4 ± 2.0

19.0 ± 2.1

0.44

 

 MUs

936.5 ± 68.2

1036.1 ± 103.8

956.6 ± 73.4

986.2 ± 76.5

0.05

 
  1. a: CBCT-H versus CBCT-L; b: CBCT-H versus MV-H; c: CBCT-H versus MV-L; d: CBCT-L versus MV-H; e: CBCT-L versus MV-L; f: MV-H versus MV-L